Pharma shares were trading higher on Sunday after Finance Minister Nirmala Sitharaman in her Budget speech said the government would unveil as a Bio Pharma Shakti scheme with an outlay of Rs 10,000 ...

Finance Minister Nirmala Sitharaman on Sunday announced a Rs 10,000 crore outlay for the Bio Pharma Shakti scheme for ...

Shortly after acquiring Elektrofi to beef up its subcutaneous drug-delivery offerings, Halozyme Therapeutics has struck ...

Union Finance Minister Nirmala Sitharaman made one of the most significant announcements of Budget 2026 by unveiling ‘Biopharma Shakti', a flagship initiative with an outlay of ₹10,000 crore over the ...

Company to meet with prospective partners as it accelerates toward IND submission for Telomir-1, with plans to begin human dosing in the first half of 2026 MIAMI, FL / ACCESS Newswire / June 2, 2025 / ...

Finance Minister Nirmala Sitharaman highlighted the growing burden of diabetes, obesity and cancer in India in her 9th Budget ...

As Samsung Biologics’ contract manufacturing business continues to fire on all cylinders, the CDMO has earned a unique ...

As part of the plan, Finance Minister Nirmala Sitharaman proposed 'Bio Pharma Shakti', a dedicated outlay of Rs 5,000 crore over five years, to accelerate capacity building and support advanced ...

DORADO, PR / ACCESS Newswire / January 29, 2026 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a regulatory affairs, quality, compliance, project management and technology ...

Patna, Feb 1 (PTI) Bihar Deputy Chief Minister Samrat Choudhary on Sunday hailed the Union Budget (2026-27) presented by ...

The MarketWatch News Department was not involved in the creation of this content. HANGZHOU, China and SHANGHAI and BOSTON, Dec. 10, 2025 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter ...

The Union Budget 2026–27 proposed a Rs 10,000 crore Bio Pharma Shakti scheme to boost biologics and biosimilars, alongside ...